"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Following promising phase 1 data, ISB 2001 has gained fast track designation from the FDA for the treatment of ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.

It allows for the visualization of all rearrangements and numerical anomalies of the samples in a single layer, providing local laboratories and/or routine hospital settings with an excellent level of ...

A Spanish study that investigated the prognostic value of immunophenotyping in patients with multiple myeloma has found that expression of the antigens CD19, CD28 and CD117 are significantly ...

providing local laboratories and/or routine hospital settings with an excellent level of detection of multiple myeloma markers, which could be described as pan-genomic technology on a human scale.